Skip to main content
. 2011 Oct 5;16(12):1684–1697. doi: 10.1634/theoncologist.2011-0113

Table 3.

Patient characteristics in the ECOG-2100, AVADO, and RIBBOn-1 trials

graphic file with name onc01211-0921-t03.jpg

Abbreviations: AVADO, Avastin and Docetaxel; ECOG, Eastern Cooperative Oncology Group; RIBBOn, Regimens in Bevacizumab for Breast Oncology; R1-Cap, RIBBOn-1/capecitabine; R1-T/Anth, RIBBOn-1/taxane and anthracycline.